Acrisure Funding: $2.1B Raised, Growth

Acrisure funding overview

Acrisure has raised $2.1B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is a Growth. Investors on record include Bain Capital, Fidelity Management & Research Company, Apollo Funds, Gallatin Point, BDT & MSD Partners. 5 distinct backers are named across the disclosed rounds.

Acrisure at a glance

Total raised

$2.1B

Latest round

Growth

Notable investors

Bain Capital, Fidelity Management & Research Company, Apollo Funds, Gallatin Point, BDT & MSD Partners

Frequently asked about Acrisure funding

How much has Acrisure raised?

Acrisure has raised $2.1B in total disclosed funding across the rounds on record.

Who has invested in Acrisure?

Bain Capital, Fidelity Management & Research Company, Apollo Funds, Gallatin Point, BDT & MSD Partners are named among the investors backing Acrisure.

What was the latest Acrisure funding round?

The most recent disclosed round is a Growth.

Where is Acrisure based?

No headquarters location is disclosed for Acrisure.

Round data for Acrisure is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.

Acrisure funding history

1 disclosed round on record.

1. Date undisclosed — Growth. $2.1B.

Companies related to Acrisure (18)

• SolarWinds
• Envestnet
• Crusoe Energy Systems
• Bridge Data Centres
• Mirakl
• CI U.S. Wealth Management
• Service Logic
• Berlin Brands Group
• Virgin Voyages
• MASAN Group
• Beeline Medicines
• Roofstock
• QuVa Pharma
• Aidacare
• Areteia Therapeutics
• Avistone Pharmaceuticals
• Frontline Road Safety
• Cardurion Pharmaceuticals

Browse related funding lists (4)

• Growth stage companies
• Companies that raised over 1b
• Companies backed by Bain Capital
• Companies backed by Fidelity Management & Research Company

Company funding database · Investor directory · Founder database · Mega-rounds 2026